Clinical Trial Update: Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)

View source ↗

Summary

This clinical trial update describes a retrospective observational study evaluating the safety and toxicity management of abemaciclib in combination with adjuva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: University Hospital, Brest | Conditions: Brest Cancer, Abemaciclib | Status: RECRUITING